FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 343:1139-1147 October 19, 2000 Number 16 Next

	Full Text PDF Editorial by Rader, D. J. Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background In patients with unstable coronary artery disease, there is a relation between the short-term risk of death and blood levels of troponin T (a marker of myocardial damage) and C-reactive protein and fibrinogen (markers of inflammation). Using information obtained during an extension of the follow-up period in the Fragmin during Instability in Coronary Artery Disease trial, we evaluated the usefulness of troponin T, C-reactive protein, and fibrinogen levels and other indicators of risk as predictors of the long-term risk of death from cardiac causes.

Methods Levels of C-reactive protein and fibrinogen at enrollment and the maximal level of troponin T during the first 24 hours after enrollment were analyzed in 917 patients included in a clinical trial of low-molecular-weight heparin in unstable coronary artery disease. The patients were followed for a mean of 37.0 months (range, 1.6 to 50.6).

Results During follow-up, 1.2 percent of the 173 patients with maximal blood troponin T levels of less than 0.06 µg per liter died of cardiac causes, as compared with 8.7 percent of the 367 patients with levels of 0.06 to 0.59 µg per liter and 15.4 percent of the 377 patients with levels of at least 0.60 µg per liter (P= 0.007 and P=0.001, respectively). The rates of death from cardiac causes were 5.7 percent among the 314 patients with blood C-reactive protein levels of less than 2 mg per liter, 7.8 percent among the 294 with levels of 2 to 10 mg per liter, and 16.5 percent among the 309 with levels of more than 10 mg per liter (P= 0.29 and P=0.001, respectively). The rates of death from cardiac causes were 5.4 percent among the 314 patients with blood fibrinogen levels of less than 3.4 g per liter, 12.0 percent among the 300 with levels of 3.4 to 3.9 g per liter, and 12.9 percent among the 303 with levels of at least 4.0 g per liter (P=0.004 and P=0.69, respectively). In a multivariate analysis, levels of troponin T and C-reactive protein were independent predictors of the risk of death from cardiac causes.

Conclusions In unstable coronary artery disease, elevated levels of troponin T and C-reactive protein are strongly related to the long-term risk of death from cardiac causes. These markers are independent risk factors, and their effects are additive with respect to each other and other clinical indicators of risk.

Source Information

From the Departments of Cardiology (B.L., H.T., L.W.) and Clinical Chemistry (A.S., P.V.), University of Uppsala, Uppsala, Sweden.

Address reprint requests to Dr. Lindahl at the Department of Cardiology, University Hospital, S-751 85 Uppsala, Sweden, or at bertil.lindahl{at}card.uas.lul.se.

Full Text of this Article

This article has been cited by other articles:

• Lurati Buse, G. A., Koller, M. T., Grapow, M., Bruni, C. M., Kasper, J., Seeberger, M. D., Filipovic, M. (2009). 12-Month Outcome After Cardiac Surgery: Prediction by Troponin T in Combination With the European System for Cardiac Operative Risk Evaluation. Ann. Thorac. Surg. 88: 1806-1812 [Abstract] [Full Text]  
• Kaski, J. C. (2009). C-reactive protein improves risk prediction in patients with acute coronary syndrome, or does it?. Eur Heart J 0: ehp435v1-ehp435 [Full Text]  
• Schiele, F., Meneveau, N., Seronde, M. F., Chopard, R., Descotes-Genon, V., Dutheil, J., Bassand, J.-P., on behalf on the 'Reseau de Cardiologie de Franche, (2009). C-reactive protein improves risk prediction in patients with acute coronary syndromes. Eur Heart J 0: ehp273v1-ehp273 [Abstract] [Full Text]  
• Hong, Y. J., Mintz, G. S., Kim, S. W., Lee, S. Y., Okabe, T., Pichard, A. D., Satler, L. F., Waksman, R., Kent, K. M., Suddath, W. O., Weissman, N. J. (2009). Impact of Plaque Composition on Cardiac Troponin Elevation After Percutaneous Coronary Intervention: An Ultrasound Analysis. J Am Coll Cardiol Img 2: 458-468 [Abstract] [Full Text]  
• Ziakas, A., Gavrilidis, S., Souliou, E., Giannoglou, G., Stiliadis, I., Karvounis, H., Efthimiadis, G., Mochlas, S., Vayona, M. A., Hatzitolios, A., Savopoulos, C., Pidonia, I., Parharidis, G. (2009). Ceruloplasmin is a Better Predictor of the Long-Term Prognosis Compared With Fibrinogen, CRP, and IL-6 in Patients With Severe Unstable Angina. ANGIOLOGY 60: 50-59 [Abstract]  
• Biasucci, L. M., Liuzzo, G., Della Bona, R., Leo, M., Biasillo, G., Angiolillo, D. J., Abbate, A., Rizzello, V., Niccoli, G., Giubilato, S., Crea, F. (2009). Different Apparent Prognostic Value of hsCRP in Type 2 Diabetic and Nondiabetic Patients with Acute Coronary Syndromes. Clin. Chem. 55: 365-368 [Abstract] [Full Text]  
• Scirica, B. M., Cannon, C. P., Sabatine, M. S., Jarolim, P., Sloane, S., Rifai, N., Braunwald, E., Morrow, D. A., for the PROVE IT-TIMI 22 Investigators, (2009). Concentrations of C-Reactive Protein and B-Type Natriuretic Peptide 30 Days after Acute Coronary Syndromes Independently Predict Hospitalization for Heart Failure and Cardiovascular Death. Clin. Chem. 55: 265-273 [Abstract] [Full Text]  
• Iijima, R, Byrne, R A, Ndrepepa, G, Braun, S, Mehilli, J, Berger, P B, Schomig, A, Kastrati, A (2009). Pre-procedural C-reactive protein levels and clinical outcomes after percutaneous coronary interventions with and without abciximab: pooled analysis of four ISAR trials. Heart 95: 107-112 [Abstract] [Full Text]  
• Venge, P., James, S., Jansson, L., Lindahl, B. (2009). Clinical Performance of Two Highly Sensitive Cardiac Troponin I Assays. Clin. Chem. 55: 109-116 [Abstract] [Full Text]  
• Hamm, C. W., Möllmann, H., Bassand, J.-P., van de Werf, F. (2009). CHAPTER 16 Acute Coronary Syndromes. ESC Textbook of Cardiovascular Medicine 2: med-9780199566990-chapter-med-9780199566990-chapter [Abstract] [Full Text]  
• Eggers, K. M., Kempf, T., Allhoff, T., Lindahl, B., Wallentin, L., Wollert, K. C. (2008). Growth-differentiation factor-15 for early risk stratification in patients with acute chest pain. Eur Heart J 29: 2327-2335 [Abstract] [Full Text]  
• Pundziute, G., Schuijf, J. D., Jukema, J. W., Decramer, I., Sarno, G., Vanhoenacker, P. K., Boersma, E., Reiber, J. H.C., Schalij, M. J., Wijns, W., Bax, J. J. (2008). Evaluation of plaque characteristics in acute coronary syndromes: non-invasive assessment with multi-slice computed tomography and invasive evaluation with intravascular ultrasound radiofrequency data analysis. Eur Heart J 29: 2373-2381 [Abstract] [Full Text]  
• Jeremias, A., Kleiman, N. S., Nassif, D., Hsieh, W.-H., Pencina, M., Maresh, K., Parikh, M., Cutlip, D. E., Waksman, R., Goldberg, S., Berger, P. B., Cohen, D. J., for the Evaluation of Drug Eluting Stents and Isch, (2008). Prevalence and Prognostic Significance of Preprocedural Cardiac Troponin Elevation Among Patients With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: Results From the Evaluation of Drug Eluting Stents and Ischemic Events Registry. Circulation 118: 632-638 [Abstract] [Full Text]  
• Bogaty, P., Boyer, L., Simard, S., Dauwe, F., Dupuis, R., Verret, B., Huynh, T., Bertrand, F., Dagenais, G. R., Brophy, J. M. (2008). Clinical utility of C-reactive protein measured at admission, hospital discharge, and 1 month later to predict outcome in patients with acute coronary disease. The RISCA (recurrence and inflammation in the acute coronary syndromes) study.. J Am Coll Cardiol 51: 2339-2346 [Abstract] [Full Text]  
• Weber, M., Bazzino, O., Navarro Estrada, J. L., Fuselli, J. J., Botto, F., Perez de Arenaza, D., Mollmann, H., Nef, H. N., Elsasser, A., Hamm, C. W. (2008). N-Terminal B-Type Natriuretic Peptide Assessment Provides Incremental Prognostic Information in Patients With Acute Coronary Syndromes and Normal Troponin T Values Upon Admission. J Am Coll Cardiol 51: 1188-1195 [Abstract] [Full Text]  
• Judge, M. S. (2008). Infection and Neuroarthropathy: The Utility of C-reactive Protein as a Screening Tool in the Charcot Foot. J. Am. Podiatr. Med. Assoc. 98: 1-6 [Abstract] [Full Text]  
• Grootendorst, D. C., de Jager, D. J., Brandenburg, V. M., Boeschoten, E. W., Krediet, R. T., Dekker, F. W., The NECOSAD Study Group, (2007). Excellent agreement between C-reactive protein measurement methods in end-stage renal disease patients no additional power for mortality prediction with high-sensitivity CRP. Nephrol Dial Transplant 22: 3277-3284 [Abstract] [Full Text]  
• Kraaijeveld, A.O., de Jager, S.C.A., de Jager, W.J., Prakken, B.J., McColl, S.R., Haspels, I., Putter, H., van Berkel, T.J.C., Nagelkerken, L., Jukema, J.W., Biessen, E.A.L. (2007). CC Chemokine Ligand-5 (CCL5/RANTES) and CC Chemokine Ligand-18 (CCL18/PARC) Are Specific Markers of Refractory Unstable Angina Pectoris and Are Transiently Raised During Severe Ischemic Symptoms. Circulation 116: 1931-1941 [Abstract] [Full Text]  
• Scirica, B. M., Morrow, D. A., Cannon, C. P., de Lemos, J. A., Murphy, S., Sabatine, M. S., Wiviott, S. D., Rifai, N., McCabe, C. H., Braunwald, E., for the Thrombolysis in Myocardial Infarction (TIM, (2007). Clinical Application of C-Reactive Protein Across the Spectrum of Acute Coronary Syndromes. Clin. Chem. 53: 1800-1807 [Abstract] [Full Text]  
• Latini, R., Masson, S., Anand, I. S., Missov, E., Carlson, M., Vago, T., Angelici, L., Barlera, S., Parrinello, G., Maggioni, A. P., Tognoni, G., Cohn, J. N., for the Val-HeFT Investigators, (2007). Prognostic Value of Very Low Plasma Concentrations of Troponin T in Patients With Stable Chronic Heart Failure. Circulation 116: 1242-1249 [Abstract] [Full Text]  
• Shah, R., Selter, J., Wang, Y., Greenspan, M., Foody, J. M. (2007). Association of Troponin Status With Guideline-Based Management of Acute Myocardial Infarction in Older Persons. Arch Intern Med 167: 1621-1628 [Abstract] [Full Text]  
• Authors/Task Force Members, , Bassand, J.-P., Hamm, C. W., Ardissino, D., Boersma, E., Budaj, A., Fernandez-Aviles, F., Fox, K. A.A., Hasdai, D., Ohman, E. M., Wallentin, L., Wijns, W., ESC Committee for Practice Guidelines (CPG), , Vahanian, A., Camm, J., De Caterina, R., Dean, V., Dickstein, K., Filippatos, G., Kristensen, S. D., Widimsky, P., McGregor, K., Sechtem, U., Tendera, M., Hellemans, I., Gomez, J. L. Z., Silber, S., Funck-Brentano, C., Document Reviewers, , Kristensen, S. D., Andreotti, F., Benzer, W., Bertrand, M., Betriu, A., De Caterina, R., DeSutter, J., Falk, V., Ortiz, A. F., Gitt, A., Hasin, Y., Huber, K., Kornowski, R., Lopez-Sendon, J., Morais, J., Nordrehaug, J. E., Silber, S., Steg, P. G., Thygesen, K., Tubaro, M., Turpie, A. G.G., Verheugt, F., Windecker, S. (2007). Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology. Eur Heart J 28: 1598-1660 [Full Text]  
• Apple, F. S., Pearce, L. A., Chung, A., Ler, R., Murakami, M. M. (2007). Multiple Biomarker Use for Detection of Adverse Events in Patients Presenting with Symptoms Suggestive of Acute Coronary Syndrome. Clin. Chem. 53: 874-881 [Abstract] [Full Text]  
• NACB WRITING GROUP MEMBERS, , Morrow, D. A., Cannon, C. P., Jesse, R. L., Newby, L. K., Ravkilde, J., Storrow, A. B., Wu, A. H.B., Christenson, R. H. (2007). National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Characteristics and Utilization of Biochemical Markers in Acute Coronary Syndromes. Circulation 115: e356-e375 [Full Text]  
• NACB WRITING GROUP MEMBERS, , Morrow, D. A., Cannon, C. P., Jesse, R. L., Newby, L. K., Ravkilde, J., Storrow, A. B., Wu, A. H.B., Christenson, R. H., NACB COMMITTEE MEMBERS, , Christenson, R. H., Apple, F. S., Cannon, C. P., Francis, G., Jesse, R. L., Morrow, D. A., Newby, L. K., Ravkilde, J., Storrow, A. B., Tang, W., Wu, A. H.B. (2007). National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Characteristics and Utilization of Biochemical Markers in Acute Coronary Syndromes. Clin. Chem. 53: 552-574 [Full Text]  
• Sabatine, M. S., Morrow, D. A., Jablonski, K. A., Rice, M. M., Warnica, J. W., Domanski, M. J., Hsia, J., Gersh, B. J., Rifai, N., Ridker, P. M, Pfeffer, M. A., Braunwald, E., for the PEACE Investigators, (2007). Prognostic Significance of the Centers for Disease Control/American Heart Association High-Sensitivity C-Reactive Protein Cut Points for Cardiovascular and Other Outcomes in Patients With Stable Coronary Artery Disease. Circulation 115: 1528-1536 [Abstract] [Full Text]  
• Oldgren, J., James, S. K., Siegbahn, A., Wallentin, L. (2007). Lipoprotein-associated phospholipase A2 does not predict mortality or new ischaemic events in acute coronary syndrome patients. Eur Heart J 28: 699-704 [Abstract] [Full Text]  
• Wollert, K. C., Kempf, T., Peter, T., Olofsson, S., James, S., Johnston, N., Lindahl, B., Horn-Wichmann, R., Brabant, G., Simoons, M. L., Armstrong, P. W., Califf, R. M., Drexler, H., Wallentin, L. (2007). Prognostic Value of Growth-Differentiation Factor-15 in Patients With Non-ST-Elevation Acute Coronary Syndrome. Circulation 115: 962-971 [Abstract] [Full Text]  
• Carrero, J. J., Fonolla, J., Marti, J. L., Jimenez, J., Boza, J. J., Lopez-Huertas, E. (2007). Intake of Fish Oil, Oleic Acid, Folic Acid, and Vitamins B-6 and E for 1 Year Decreases Plasma C-Reactive Protein and Reduces Coronary Heart Disease Risk Factors in Male Patients in a Cardiac Rehabilitation Program. J. Nutr. 137: 384-390 [Abstract] [Full Text]  
• Kavsak, P. A., Newman, A. M., Lustig, V., MacRae, A. R., Palomaki, G. E., Ko, D. T., Tu, J. V., Jaffe, A. S. (2007). Long-Term Health Outcomes Associated with Detectable Troponin I Concentrations. Clin. Chem. 53: 220-227 [Abstract] [Full Text]  
• Antoniucci, D. (2007). Differences among GP IIb/IIIa inhibitors: different clinical benefits in non-ST-segment elevation acute coronary syndrome percutaneous coronary intervention patients. Eur Heart J Suppl 9: A32-A36 [Abstract] [Full Text]  
• Liuzzo, G., Santamaria, M., Biasucci, L. M., Narducci, M., Colafrancesco, V., Porto, A., Brugaletta, S., Pinnelli, M., Rizzello, V., Maseri, A., Crea, F. (2007). Persistent Activation of Nuclear Factor Kappa-B Signaling Pathway in Patients With Unstable Angina and Elevated Levels of C-Reactive Protein: Evidence for a Direct Proinflammatory Effect of Azide and Lipopolysaccharide-Free C-Reactive Protein on Human Monocytes Via Nuclear Factor Kappa-B Activation. J Am Coll Cardiol 49: 185-194 [Abstract] [Full Text]  
• Fox, K. A A, Dabbous, O. H, Goldberg, R. J, Pieper, K. S, Eagle, K. A, Van de Werf, F., Avezum, A., Goodman, S. G, Flather, M. D, Anderson, F. A Jr, Granger, C. B (2006). Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ 333: 1091-1091 [Abstract] [Full Text]  
• Heras, M, Bueno, H, Bardaji, A, Fernandez-Ortiz, A, Marti, H, Marrugat, J, on behalf of the DESCARTES Investigators, (2006). Magnitude and consequences of undertreatment of high-risk patients with non-ST segment elevation acute coronary syndromes: insights from the DESCARTES Registry. Heart 92: 1571-1576 [Abstract] [Full Text]  
• Libby, P., Ridker, P. M. (2006). Inflammation and Atherothrombosis: From Population Biology and Bench Research to Clinical Practice. J Am Coll Cardiol 48: A33-A46 [Abstract] [Full Text]  
• James, S. K., Lindback, J., Tilly, J., Siegbahn, A., Venge, P., Armstrong, P., Califf, R., Simoons, M. L., Wallentin, L., Lindahl, B. (2006). Troponin-T and N-Terminal Pro-B-Type Natriuretic Peptide Predict Mortality Benefit From Coronary Revascularization in Acute Coronary Syndromes: A GUSTO-IV Substudy. J Am Coll Cardiol 48: 1146-1154 [Abstract] [Full Text]  
• Westerhout, C. M., Fu, Y., Lauer, M. S., James, S., Armstrong, P. W., Al-Hattab, E., Califf, R. M., Simoons, M. L., Wallentin, L., Boersma, E., on behalf of the GUSTO-IV ACS Trial Investigators, (2006). Short- and Long-Term Risk Stratification in Acute Coronary Syndromes: The Added Value of Quantitative ST-Segment Depression and Multiple Biomarkers. J Am Coll Cardiol 48: 939-947 [Abstract] [Full Text]  
• O'Donoghue, M., de Lemos, J. A., Morrow, D. A., Murphy, S. A., Buros, J. L., Cannon, C. P., Sabatine, M. S. (2006). Prognostic Utility of Heart-Type Fatty Acid Binding Protein in Patients With Acute Coronary Syndromes. Circulation 114: 550-557 [Abstract] [Full Text]  
• Minoguchi, K., Yokoe, T., Tanaka, A., Ohta, S., Hirano, T., Yoshino, G., O'Donnell, C. P., Adachi, M. (2006). Association between lipid peroxidation and inflammation in obstructive sleep apnoea.. Eur Respir J 28: 378-385 [Abstract] [Full Text]  
• Blankenberg, S., McQueen, M. J., Smieja, M., Pogue, J., Balion, C., Lonn, E., Rupprecht, H. J., Bickel, C., Tiret, L., Cambien, F., Gerstein, H., Munzel, T., Yusuf, S., for the HOPE Study Investigators, (2006). Comparative Impact of Multiple Biomarkers and N-Terminal Pro-Brain Natriuretic Peptide in the Context of Conventional Risk Factors for the Prediction of Recurrent Cardiovascular Events in the Heart Outcomes Prevention Evaluation (HOPE) Study. Circulation 114: 201-208 [Abstract] [Full Text]  
• Bugiardini, R. (2006). Women, 'non-specific' chest pain, and normal or near-normal coronary angiograms are not synonymous with favourable outcome. Eur Heart J 27: 1387-1389 [Full Text]  
• Scirica, B. M., Morrow, D. A., Verma, S., Devaraj, S., Jialal, I., Scirica, B. M., Morrow, D. A., Verma, S., Devaraj, S., Jialal, I. (2006). The Verdict Is Still Out. Circulation 113: 2128-2151 [Full Text]  
• Lucas, A. R., Korol, R., Pepine, C. J. (2006). Inflammation in Atherosclerosis: Some Thoughts About Acute Coronary Syndromes. Circulation 113: e728-e732 [Full Text]  
• Ziakas, A., Gavrilidis, S., Giannoglou, G., Souliou, E., Gemitzis, K., Kalampalika, D., Vayona, M. A., Pidonia, I., Parharidis, G., Louridas, G. (2006). In-Hospital and Long-Term Prognostic Value of Fibrinogen, CRP, and IL-6 Levels in Patients with Acute Myocardial Infarction Treated with Thrombolysis. ANGIOLOGY 57: 283-293 [Abstract]  
• James, S., Flodin, M., Johnston, N., Lindahl, B., Venge, P. (2006). The Antibody Configurations of Cardiac Troponin I Assays May Determine Their Clinical Performance. Clin. Chem. 52: 832-837 [Abstract] [Full Text]  
• Tsimikas, S., Willerson, J. T., Ridker, P. M. (2006). C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients.. J Am Coll Cardiol 47: C19-C31 [Abstract] [Full Text]  
• Zethelius, B., Johnston, N., Venge, P. (2006). Troponin I as a Predictor of Coronary Heart Disease and Mortality in 70-Year-Old Men: A Community-Based Cohort Study. Circulation 113: 1071-1078 [Abstract] [Full Text]  
• Armstrong, E. J., Morrow, D. A., Sabatine, M. S. (2006). Inflammatory Biomarkers in Acute Coronary Syndromes: Part II: Acute-Phase Reactants and Biomarkers of Endothelial Cell Activation. Circulation 113: e152-e155 [Full Text]  
• Henry, C. R., Satran, D., Lindgren, B., Adkinson, C., Nicholson, C. I., Henry, T. D. (2006). Myocardial Injury and Long-term Mortality Following Moderate to Severe Carbon Monoxide Poisoning. JAMA 295: 398-402 [Abstract] [Full Text]  
• Boos, C. J., Anderson, R. A., Lip, G. Y.H. (2006). Is atrial fibrillation an inflammatory disorder?. Eur Heart J 27: 136-149 [Abstract] [Full Text]  
• Babuin, L., Jaffe, A. S. (2005). Troponin: the biomarker of choice for the detection of cardiac injury. CMAJ 173: 1191-1202 [Abstract] [Full Text]  
• Ginsburg, G. S., Donahue, M. P., Newby, L. K. (2005). Prospects for Personalized Cardiovascular Medicine: The Impact of Genomics. J Am Coll Cardiol 46: 1615-1627 [Abstract] [Full Text]  
• Saleh, N., Svane, B., Hansson, L.-O., Jensen, J., Nilsson, T., Danielsson, O., Tornvall, P. (2005). Response of Serum C-Reactive Protein to Percutaneous Coronary Intervention Has Prognostic Value. Clin. Chem. 51: 2124-2130 [Abstract] [Full Text]  
• Ray, K. K., Cannon, C. P. (2005). The Potential Relevance of the Multiple Lipid-Independent (Pleiotropic) Effects of Statins in the Management of Acute Coronary Syndromes. J Am Coll Cardiol 46: 1425-1433 [Abstract] [Full Text]  
• De Servi, S., Mariani, M., Mariani, G., Mazzone, A. (2005). C-Reactive Protein Increase in Unstable Coronary Disease: Cause or Effect?. J Am Coll Cardiol 46: 1496-1502 [Abstract] [Full Text]  
• Mallat, Z., Steg, Ph. G., Benessiano, J., Tanguy, M.-L., Fox, K. A., Collet, J.-P., Dabbous, O. H., Henry, P., Carruthers, K. F., Dauphin, A., Arguelles, C. S., Masliah, J., Hugel, B., Montalescot, G., Freyssinet, J.-M., Asselain, B., Tedgui, A. (2005). Circulating Secretory Phospholipase A2 Activity Predicts Recurrent Events in Patients With Severe Acute Coronary Syndromes. J Am Coll Cardiol 46: 1249-1257 [Abstract] [Full Text]  
• Lakka, T. A., Lakka, H.-M., Rankinen, T., Leon, A. S., Rao, D.C., Skinner, J. S., Wilmore, J. H., Bouchard, C. (2005). Effect of exercise training on plasma levels of C-reactive protein in healthy adults: the HERITAGE Family Study. Eur Heart J 26: 2018-2025 [Abstract] [Full Text]  
• Biasucci, L M, Giubilato, G, Graziani, F, Piro, M (2005). CRP is or is not a reliable marker of ischaemic heart disease?. Lupus 14: 752-755 [Abstract]  
• Lagerqvist, B, Diderholm, E, Lindahl, B, Husted, S, Kontny, F, Stahle, E, Swahn, E, Venge, P, Siegbahn, A, Wallentin, L (2005). FRISC score for selection of patients for an early invasive treatment strategy in unstable coronary artery disease. Heart 91: 1047-1052 [Abstract] [Full Text]  
• Priebe, H.-J. (2005). Perioperative myocardial infarction--aetiology and prevention. Br J Anaesth 95: 3-19 [Abstract] [Full Text]  
• Kilickap, S., Barista, I., Akgul, E., Aytemir, K., Aksoyek, S., Aksoy, S., Celik, I., Kes, S., Tekuzman, G. (2005). cTnT can be a useful marker for early detection of anthracycline cardiotoxicity. Ann Oncol 16: 798-804 [Abstract] [Full Text]  
• Hansson, G. K. (2005). Inflammation, Atherosclerosis, and Coronary Artery Disease. NEJM 352: 1685-1695 [Full Text]  
• Yip, H.-K., Hang, C.-L., Fang, C.-Y., Hsieh, Y.-K., Yang, C.-H., Hung, W.-C., Wu, C.-J. (2005). Level of High-Sensitivity C-Reactive Protein Is Predictive of 30-Day Outcomes in Patients With Acute Myocardial Infarction Undergoing Primary Coronary Intervention. Chest 127: 803-808 [Abstract] [Full Text]  
• Schnabel, R., Rupprecht, H. J., Lackner, K. J., Lubos, E., Bickel, C., Meyer, J., Munzel, T., Cambien, F., Tiret, L., Blankenberg, S., for the AtheroGene Investigators, (2005). Analysis of N-terminal-pro-brain natriuretic peptide and C-reactive protein for risk stratification in stable and unstable coronary artery disease: results from the AtheroGene study. Eur Heart J 26: 241-249 [Abstract] [Full Text]  
• Gluckman, T. J., Sachdev, M., Schulman, S. P., Blumenthal, R. S. (2005). A Simplified Approach to the Management of Non-ST-Segment Elevation Acute Coronary Syndromes. JAMA 293: 349-357 [Abstract] [Full Text]  
• Heeschen, C., Dimmeler, S., Hamm, C. W., Fichtlscherer, S., Simoons, M. L., Zeiher, A. M., CAPTURE Study Investigators, (2005). Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: Comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis. J Am Coll Cardiol 45: 229-237 [Abstract] [Full Text]  
• Ridker, P. M, Cannon, C. P., Morrow, D., Rifai, N., Rose, L. M., McCabe, C. H., Pfeffer, M. A., Braunwald, E., the Pravastatin or Atorvastatin Evaluation and Inf, (2005). C-Reactive Protein Levels and Outcomes after Statin Therapy. NEJM 352: 20-28 [Abstract] [Full Text]  
• Biasucci, L. M. (2004). CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: Clinical Use of Inflammatory Markers in Patients With Cardiovascular Diseases: A Background Paper. Circulation 110: e560-e567 [Abstract] [Full Text]  
• Smeeth, L., Thomas, S. L., Hall, A. J., Hubbard, R., Farrington, P., Vallance, P. (2004). Risk of Myocardial Infarction and Stroke after Acute Infection or Vaccination. NEJM 351: 2611-2618 [Abstract] [Full Text]  
• Madjid, M., Awan, I., Willerson, J. T., Casscells, S. W. (2004). Leukocyte count and coronary heart disease: Implications for risk assessment. J Am Coll Cardiol 44: 1945-1956 [Abstract] [Full Text]  
• Gibson, C. M., Dumaine, R. L., Gelfand, E. V., Murphy, S. A., Morrow, D. A., Wiviott, S. D., Giugliano, R. P., Cannon, C. P., Antman, E. M., Braunwald, E., For the TIMI Study Group, (2004). Association of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome; observations in 13307 patients in five TIMI trials. Eur Heart J 25: 1998-2005 [Abstract] [Full Text]  
• Latini, R., Maggioni, A. P., Peri, G., Gonzini, L., Lucci, D., Mocarelli, P., Vago, L., Pasqualini, F., Signorini, S., Soldateschi, D., Tarli, L., Schweiger, C., Fresco, C., Cecere, R., Tognoni, G., Mantovani, A., on behalf of the Lipid Assessment Trial Italian Ne, (2004). Prognostic Significance of the Long Pentraxin PTX3 in Acute Myocardial Infarction. Circulation 110: 2349-2354 [Abstract] [Full Text]  
• Jennings, J. R., Kamarck, T. W., Everson-Rose, S. A., Kaplan, G. A., Manuck, S. B., Salonen, J.T. (2004). Exaggerated Blood Pressure Responses During Mental Stress Are Prospectively Related to Enhanced Carotid Atherosclerosis in Middle-Aged Finnish Men. Circulation 110: 2198-2203 [Abstract] [Full Text]  
• Jernberg, T., James, S., Lindahl, B., Johnston, N., Stridsberg, M., Venge, P., Wallentin, L. (2004). Natriuretic peptides in unstable coronary artery disease. Eur Heart J 25: 1486-1493 [Abstract] [Full Text]  
• Landesberg, G., Mosseri, M., Shatz, V., Akopnik, I., Bocher, M., Mayer, M., Anner, H., Berlatzky, Y., Weissman, C. (2004). Cardiac troponin after major vascular surgery: The role of perioperative ischemia, preoperative thallium scanning, and coronary revascularization. J Am Coll Cardiol 44: 569-575 [Abstract] [Full Text]  
• Hu, P., Reuben, D. B., Crimmins, E. M., Harris, T. B., Huang, M.-H., Seeman, T. E. (2004). The Effects of Serum Beta-Carotene Concentration and Burden of Inflammation on All-Cause Mortality Risk in High-Functioning Older Persons: MacArthur Studies of Successful Aging. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 59: M849-M854 [Abstract] [Full Text]  
• Iribarren, C., Tolstykh, I. V, Eisner, M. D (2004). Are patients with asthma at increased risk of coronary heart disease?. Int J Epidemiol 33: 743-748 [Abstract] [Full Text]  
• Panteghini, M. (2004). Role and importance of biochemical markers in clinical cardiology. Eur Heart J 25: 1187-1196 [Abstract] [Full Text]  
• Bugiardini, R (2004). Risk stratification in acute coronary syndrome: focus on unstable angina/non-ST segment elevation myocardial infarction. Heart 90: 729-731 [Abstract] [Full Text]  
• Norgaard, B L, Andersen, K, Thygesen, K, Ravkilde, J, Abrahamsson, P, Grip, L, Dellborg, M (2004). Long term risk stratification of patients with acute coronary syndromes: characteristics of troponin T testing and continuous ST segment monitoring. Heart 90: 739-744 [Abstract] [Full Text]  
• Ridker, P. M, Brown, N. J., Vaughan, D. E., Harrison, D. G., Mehta, J. L. (2004). Established and Emerging Plasma Biomarkers in the Prediction of First Atherothrombotic Events. Circulation 109: IV-6-IV-19 [Full Text]  
• Davignon, J. (2004). Beneficial Cardiovascular Pleiotropic Effects of Statins. Circulation 109: III-39-III-43 [Abstract] [Full Text]  
• Fox, K. A A (2004). Management of acute coronary syndromes: an update. Heart 90: 698-706 [Full Text]  
• Granger, C. B., Van Eyk, J. E., Mockrin, S. C., Anderson, N. L., on behalf of the Working Group Members, (2004). National Heart, Lung, and Blood Institute Clinical Proteomics Working Group Report. Circulation 109: 1697-1703 [Abstract] [Full Text]  
• Gao, X., Bermudez, O. I., Tucker, K. L. (2004). Plasma C-Reactive Protein and Homocysteine Concentrations Are Related to Frequent Fruit and Vegetable Intake in Hispanic and Non-Hispanic White Elders. J. Nutr. 134: 913-918 [Abstract] [Full Text]  
• Kontos, M. C., Shah, R., Fritz, L. M., Anderson, F. P., Tatum, J. L., Ornato, J. P., Jesse, R. L. (2004). Implication of different cardiac troponin I levels for clinical outcomes and prognosis of acute chest pain patients. J Am Coll Cardiol 43: 958-965 [Abstract] [Full Text]  
• Milani, R. V., Lavie, C. J., Mehra, M. R. (2004). Reduction in C-reactive protein through cardiac rehabilitation and exercise training. J Am Coll Cardiol 43: 1056-1061 [Abstract] [Full Text]  
• Jernberg, T., James, S., Lindahl, B., Stridsberg, M., Venge, P., Wallentin, L. (2004). NT-proBNP in unstable coronary artery disease--experiences from the FAST, GUSTO IV and FRISC II trials. Eur J Heart Fail 6: 319-325 [Abstract] [Full Text]